[HTML][HTML] Comparison of current systemic combination therapies for metastatic hormone-sensitive prostate cancer and selection of candidates for optimal treatment: a …
J Chen, Y Ni, G Sun, B Liao, X Zhang, J Zhao… - Frontiers in …, 2020 - frontiersin.org
Objective: To compare the efficacy and safety of current systemic combination therapies for
patients with mHSPC and help select candidates for optimal treatment. Methods: Databases …
patients with mHSPC and help select candidates for optimal treatment. Methods: Databases …
Comparison of Current Systemic Combination Therapies for Metastatic Hormone-Sensitive Prostate Cancer and Selection of Candidates for Optimal Treatment: A …
J Chen, Y Ni, G Sun, B Liao, X Zhang, J Zhao… - Frontiers in …, 2020 - europepmc.org
Objective: To compare the efficacy and safety of current systemic combination therapies for
patients with mHSPC and help select candidates for optimal treatment. Methods: Databases …
patients with mHSPC and help select candidates for optimal treatment. Methods: Databases …
[PDF][PDF] Comparison of Current Systemic Combination Therapies for Metastatic Hormone-Sensitive Prostate Cancer and Selection of Candidates for Optimal Treatment …
J Chen, Y Ni, G Sun, B Liao, X Zhang, J Zhao, S Zhu… - Oncol, 2020 - researchgate.net
Objective: To compare the efficacy and safety of current systemic combination therapies for
patients with mHSPC and help select candidates for optimal treatment. Methods: Databases …
patients with mHSPC and help select candidates for optimal treatment. Methods: Databases …
[HTML][HTML] Comparison of Current Systemic Combination Therapies for Metastatic Hormone-Sensitive Prostate Cancer and Selection of Candidates for Optimal …
J Chen, Y Ni, G Sun, B Liao, X Zhang, J Zhao… - Frontiers in …, 2020 - ncbi.nlm.nih.gov
Objective: To compare the efficacy and safety of current systemic combination therapies for
patients with mHSPC and help select candidates for optimal treatment. Methods: Databases …
patients with mHSPC and help select candidates for optimal treatment. Methods: Databases …
Comparison of Current Systemic Combination Therapies for Metastatic Hormone-Sensitive Prostate Cancer and Selection of Candidates for Optimal Treatment: A …
J Chen, Y Ni, G Sun, B Liao, X Zhang… - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
Objective: To compare the efficacy and safety of current systemic combination therapies for
patients with mHSPC and help select candidates for optimal treatment. Methods: Databases …
patients with mHSPC and help select candidates for optimal treatment. Methods: Databases …